Dr Scott Kollins from the Duke University School of Medicine based in the U.S. lends his expertise and thought leadership to support TALi’s evidence generation strategy. Dr Kollins is a Professor in the Department of Psychiatry and Behavioral Sciences at the Duke University School of Medicine, based in Durham, North Carolina. Dr Kollins also serves as the Global Lead for ADHD and Substance Use Disorders at the Duke Clinical Research Institute and the Director of the Duke ADHD Program.
Dr Kollins received his undergraduate degree in psychology from Duke University, and his graduate degree in Clinical Psychology from Auburn University. Dr Kollins has published more than 150 scientific papers and his research has been supported by seven different U.S. federal agencies, including NICHD, NIDA, NIMH, NIEHS, NINDS, FDA, and EPA.